Cargando…
Maculopapular Exanthema After the Second Dose of Evolocumab
Evolocumab is a relatively new monoclonal antibody designed to decrease low-density lipoproteins via the inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9). It is used alone or in combination with other lipid-lowering agents. Evolocumab was associated with adverse events of skin ras...
Autores principales: | Ghernautan, Victoria, Amini, Masoud, Sachmechi, Issac |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229243/ https://www.ncbi.nlm.nih.gov/pubmed/34188988 http://dx.doi.org/10.7759/cureus.15249 |
Ejemplares similares
-
New-Onset Diabetes in the Setting of Beta-Cell Dysfunction in a Young Patient With COVID-19 Infection
por: Alshamam, Mohsen S, et al.
Publicado: (2021) -
Effect of High-dose Biotin on Thyroid Function Tests: Case Report and Literature Review
por: Ardabilygazir, Arash, et al.
Publicado: (2018) -
Malignant Hypertension in Association with Low Estrogen Dose Oral Contraceptives: Case Report and Review of Literature
por: Mir, Danial, et al.
Publicado: (2018) -
Prolonged Duration of Hashitoxicosis in a Patient with Hashimoto’s Thyroiditis: A Case Report and Review of Literature
por: Shahbaz, Amir, et al.
Publicado: (2018) -
Adult-onset Still’s Disease in a Female Patient with Schizophrenia: A Case Report and Literature Review
por: Golchin, Nasim, et al.
Publicado: (2018)